Detailed TOC of Codeine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2034
1 Market Overview
1.1 Codeine Product Introduction
1.2 Global Codeine Market Size Forecast
1.2.1 Global Codeine Sales Value (2019-2034)
1.2.2 Global Codeine Sales Volume (2019-2034)
1.2.3 Global Codeine Sales Price (2019-2034)
1.3 Codeine Market Trends & Drivers
1.3.1 Codeine Industry Trends
1.3.2 Codeine Market Drivers & Opportunity
1.3.3 Codeine Market Challenges
1.3.4 Codeine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Codeine Players Revenue Ranking (2025)
2.2 Global Codeine Revenue by Company (2019-2025)
2.3 Global Codeine Players Sales Volume Ranking (2025)
2.4 Global Codeine Sales Volume by Company Players (2019-2025)
2.5 Global Codeine Average Price by Company (2019-2025)
2.6 Key Manufacturers Codeine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Codeine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Codeine
2.9 Codeine Market Competitive Analysis
2.9.1 Codeine Market Concentration Rate (2019-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Codeine Revenue in 2025
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Codeine as of 2025)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Ingredient
3.1 Introduction by Ingredient
3.1.1 Single-ingredient Codeine
3.1.2 Multi-ingredient Medications
3.2 Global Codeine Sales Value by Ingredient
3.2.1 Global Codeine Sales Value by Ingredient (2019 VS 2025 VS 2034)
3.2.2 Global Codeine Sales Value, by Ingredient (2019-2034)
3.2.3 Global Codeine Sales Value, by Ingredient (%) (2019-2034)
3.3 Global Codeine Sales Volume by Ingredient
3.3.1 Global Codeine Sales Volume by Ingredient (2019 VS 2025 VS 2034)
3.3.2 Global Codeine Sales Volume, by Ingredient (2019-2034)
3.3.3 Global Codeine Sales Volume, by Ingredient (%) (2019-2034)
3.4 Global Codeine Average Price by Ingredient (2019-2034)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Narcotic Analgesic
4.1.2 Antitussive
4.1.3 Others
4.2 Global Codeine Sales Value by Application
4.2.1 Global Codeine Sales Value by Application (2019 VS 2025 VS 2034)
4.2.2 Global Codeine Sales Value, by Application (2019-2034)
4.2.3 Global Codeine Sales Value, by Application (%) (2019-2034)
4.3 Global Codeine Sales Volume by Application
4.3.1 Global Codeine Sales Volume by Application (2019 VS 2025 VS 2034)
4.3.2 Global Codeine Sales Volume, by Application (2019-2034)
4.3.3 Global Codeine Sales Volume, by Application (%) (2019-2034)
4.4 Global Codeine Average Price by Application (2019-2034)
5 Segmentation by Region
5.1 Global Codeine Sales Value by Region
5.1.1 Global Codeine Sales Value by Region: 2019 VS 2025 VS 2034
5.1.2 Global Codeine Sales Value by Region (2019-2025)
5.1.3 Global Codeine Sales Value by Region (2025-2034)
5.1.4 Global Codeine Sales Value by Region (%), (2019-2034)
5.2 Global Codeine Sales Volume by Region
5.2.1 Global Codeine Sales Volume by Region: 2019 VS 2025 VS 2034
5.2.2 Global Codeine Sales Volume by Region (2019-2025)
5.2.3 Global Codeine Sales Volume by Region (2025-2034)
5.2.4 Global Codeine Sales Volume by Region (%), (2019-2034)
5.3 Global Codeine Average Price by Region (2019-2034)
5.4 North America
5.4.1 North America Codeine Sales Value, 2019-2034
5.4.2 North America Codeine Sales Value by Country (%), 2025 VS 2034
5.5 Europe
5.5.1 Europe Codeine Sales Value, 2019-2034
5.5.2 Europe Codeine Sales Value by Country (%), 2025 VS 2034
5.6 Asia Pacific
5.6.1 Asia Pacific Codeine Sales Value, 2019-2034
5.6.2 Asia Pacific Codeine Sales Value by Country (%), 2025 VS 2034
5.7 South America
5.7.1 South America Codeine Sales Value, 2019-2034
5.7.2 South America Codeine Sales Value by Country (%), 2025 VS 2034
5.8 Middle East & Africa
5.8.1 Middle East & Africa Codeine Sales Value, 2019-2034
5.8.2 Middle East & Africa Codeine Sales Value by Country (%), 2025 VS 2034
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Codeine Sales Value Growth Trends, 2019 VS 2025 VS 2034
6.2 Key Countries/Regions Codeine Sales Value
6.2.1 Key Countries/Regions Codeine Sales Value, 2019-2034
6.2.2 Key Countries/Regions Codeine Sales Volume, 2019-2034
6.3 United States
6.3.1 United States Codeine Sales Value, 2019-2034
6.3.2 United States Codeine Sales Value by Ingredient (%), 2025 VS 2034
6.3.3 United States Codeine Sales Value by Application, 2025 VS 2034
6.4 Europe
6.4.1 Europe Codeine Sales Value, 2019-2034
6.4.2 Europe Codeine Sales Value by Ingredient (%), 2025 VS 2034
6.4.3 Europe Codeine Sales Value by Application, 2025 VS 2034
6.5 China
6.5.1 China Codeine Sales Value, 2019-2034
6.5.2 China Codeine Sales Value by Ingredient (%), 2025 VS 2034
6.5.3 China Codeine Sales Value by Application, 2025 VS 2034
6.6 Japan
6.6.1 Japan Codeine Sales Value, 2019-2034
6.6.2 Japan Codeine Sales Value by Ingredient (%), 2025 VS 2034
6.6.3 Japan Codeine Sales Value by Application, 2025 VS 2034
6.7 South Korea
6.7.1 South Korea Codeine Sales Value, 2019-2034
6.7.2 South Korea Codeine Sales Value by Ingredient (%), 2025 VS 2034
6.7.3 South Korea Codeine Sales Value by Application, 2025 VS 2034
6.8 Southeast Asia
6.8.1 Southeast Asia Codeine Sales Value, 2019-2034
6.8.2 Southeast Asia Codeine Sales Value by Ingredient (%), 2025 VS 2034
6.8.3 Southeast Asia Codeine Sales Value by Application, 2025 VS 2034
6.9 India
6.9.1 India Codeine Sales Value, 2019-2034
6.9.2 India Codeine Sales Value by Ingredient (%), 2025 VS 2034
6.9.3 India Codeine Sales Value by Application, 2025 VS 2034
7 Company Profiles
7.1 Taiji
7.1.1 Taiji Company Information
7.1.2 Taiji Introduction and Business Overview
7.1.3 Taiji Codeine Sales, Revenue and Gross Margin (2019-2025)
7.1.4 Taiji Codeine Product Offerings
7.1.5 Taiji Recent Development
7.2 Mallinckrodt
7.2.1 Mallinckrodt Company Information
7.2.2 Mallinckrodt Introduction and Business Overview
7.2.3 Mallinckrodt Codeine Sales, Revenue and Gross Margin (2019-2025)
7.2.4 Mallinckrodt Codeine Product Offerings
7.2.5 Mallinckrodt Recent Development
7.3 TEVA
7.3.1 TEVA Company Information
7.3.2 TEVA Introduction and Business Overview
7.3.3 TEVA Codeine Sales, Revenue and Gross Margin (2019-2025)
7.3.4 TEVA Codeine Product Offerings
7.3.5 TEVA Recent Development
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Information
7.4.2 Johnson & Johnson Introduction and Business Overview
7.4.3 Johnson & Johnson Codeine Sales, Revenue and Gross Margin (2019-2025)
7.4.4 Johnson & Johnson Codeine Product Offerings
7.4.5 Johnson & Johnson Recent Development
7.5 Medreich
7.5.1 Medreich Company Information
7.5.2 Medreich Introduction and Business Overview
7.5.3 Medreich Codeine Sales, Revenue and Gross Margin (2019-2025)
7.5.4 Medreich Codeine Product Offerings
7.5.5 Medreich Recent Development
7.6 Sanofi Aventis
7.6.1 Sanofi Aventis Company Information
7.6.2 Sanofi Aventis Introduction and Business Overview
7.6.3 Sanofi Aventis Codeine Sales, Revenue and Gross Margin (2019-2025)
7.6.4 Sanofi Aventis Codeine Product Offerings
7.6.5 Sanofi Aventis Recent Development
7.7 Cipla
7.7.1 Cipla Company Information
7.7.2 Cipla Introduction and Business Overview
7.7.3 Cipla Codeine Sales, Revenue and Gross Margin (2019-2025)
7.7.4 Cipla Codeine Product Offerings
7.7.5 Cipla Recent Development
7.8 Hikma
7.8.1 Hikma Company Information
7.8.2 Hikma Introduction and Business Overview
7.8.3 Hikma Codeine Sales, Revenue and Gross Margin (2019-2025)
7.8.4 Hikma Codeine Product Offerings
7.8.5 Hikma Recent Development
7.9 Pharmaceutical Associates
7.9.1 Pharmaceutical Associates Company Information
7.9.2 Pharmaceutical Associates Introduction and Business Overview
7.9.3 Pharmaceutical Associates Codeine Sales, Revenue and Gross Margin (2019-2025)
7.9.4 Pharmaceutical Associates Codeine Product Offerings
7.9.5 Pharmaceutical Associates Recent Development
7.10 Novartis
7.10.1 Novartis Company Information
7.10.2 Novartis Introduction and Business Overview
7.10.3 Novartis Codeine Sales, Revenue and Gross Margin (2019-2025)
7.10.4 Novartis Codeine Product Offerings
7.10.5 Novartis Recent Development
7.11 Apotex
7.11.1 Apotex Company Information
7.11.2 Apotex Introduction and Business Overview
7.11.3 Apotex Codeine Sales, Revenue and Gross Margin (2019-2025)
7.11.4 Apotex Codeine Product Offerings
7.11.5 Apotex Recent Development
7.12 Mylan
7.12.1 Mylan Company Information
7.12.2 Mylan Introduction and Business Overview
7.12.3 Mylan Codeine Sales, Revenue and Gross Margin (2019-2025)
7.12.4 Mylan Codeine Product Offerings
7.12.5 Mylan Recent Development
7.13 Aristo Pharma GmbH
7.13.1 Aristo Pharma GmbH Company Information
7.13.2 Aristo Pharma GmbH Introduction and Business Overview
7.13.3 Aristo Pharma GmbH Codeine Sales, Revenue and Gross Margin (2019-2025)
7.13.4 Aristo Pharma GmbH Codeine Product Offerings
7.13.5 Aristo Pharma GmbH Recent Development
7.14 Lannett Company
7.14.1 Lannett Company Company Information
7.14.2 Lannett Company Introduction and Business Overview
7.14.3 Lannett Company Codeine Sales, Revenue and Gross Margin (2019-2025)
7.14.4 Lannett Company Codeine Product Offerings
7.14.5 Lannett Company Recent Development
7.15 Laboratoire Riva
7.15.1 Laboratoire Riva Company Information
7.15.2 Laboratoire Riva Introduction and Business Overview
7.15.3 Laboratoire Riva Codeine Sales, Revenue and Gross Margin (2019-2025)
7.15.4 Laboratoire Riva Codeine Product Offerings
7.15.5 Laboratoire Riva Recent Development
8 Industry Chain Analysis
8.1 Codeine Industrial Chain
8.2 Codeine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Codeine Sales Model
8.5.2 Sales Channel
8.5.3 Codeine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Download FREE Sample Report
